Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001437749-25-035232
Filing Date
2025-11-14
Accepted
2025-11-14 16:48:12
Documents
1
Period of Report
2025-11-13

Document Format Files

Seq Description Document Type Size
1 FORM 4 rdgdoc.html 4  
1 FORM 4 rdgdoc.xml 4 3613
  Complete submission text file 0001437749-25-035232.txt   5144
Mailing Address 6550 SOUTH MILLROCK DRIVE, SUITE G50 SALT LAKE CITY UT 84121
Business Address 6550 SOUTH MILLROCK DRIVE, SUITE G50 SALT LAKE CITY UT 84121 801-676-9695
Clene Inc. (Issuer) CIK: 0001822791 (see all company filings)

EIN.: 852828339 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)

Mailing Address 500 PRINCIPIO PARKWAY WEST SUITE 400 NORTH EAST MD 21901
Business Address
Kiernan Matthew (Reporting) CIK: 0001993183 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-39834 | Film No.: 251487673